Results 131 to 140 of about 66,683 (210)

Is antiviral therapy against HHV-6B beneficial? [PDF]

Blood, 2020
openaire   +2 more sources

Summary of HHV-6B proteins identified by LC/MS^E in gel-fractions that induced IFN-γ responses.

, 2015
1. Virus: extracellular HHV-6B virus; Cell lysate: lysate of HHV-6B-infected cellsSummary of HHV-6B proteins identified by LC/MSE in gel-fractions that induced IFN-γ responses.
Lawrence J. Stern (49046), Aniuska Becerra-Artiles (829447), Omar Dominguez-Amorocho (829448), J. Mauricio Calvo-Calle (80390)   +3 more
core   +1 more source

HHV-6B infection rescues cells from p53-dependent apoptosis.

, 2013
(A & B) Western blot analysis of PARP cleavage in cells either mock-treated or infected with HHV-6B for 48 hrs. The cells were subsequently treated with mock, leupeptin (10 µM), UV radiation (10 min exposure followed by 4 hrs of incubation), doxorubicin (
Rasmus O. Bak (124809), Emil Kofod-Olsen (299890), Janni M. L. Møller (369948), Mariane H. Schleimann (369947), Jacob G. Mikkelsen (394329), Bettina Bundgaard (394327), Ted Hupp (272960), Bodil Øster (394328), Per Höllsberg (299893)   +8 more
core   +1 more source

Antigen presentation by cells infected with HHV-6B and HHV-6A.

, 2018
HLA-B*08:01-matched PHA-activated CD4 T cells were infected with HHV-6B strain HST (panel A) or HHV-6A strain U1102 (panel B). As a further control, the viral replication inhibitor ganciclovir (GCV) was added where indicated.
Christoph Hübener (4751847), Alexandra Hollaus (5146064), Johanna Tischer (3449726), Larissa K. Martin (5146061), Anna Stahuber (5146070), Andrea Schub (5146067), Andreas Moosmann (38220), Alessia Fraccaroli (124908)   +7 more
core   +1 more source

The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling

EMBO Reports
Viral infection often trigger an ATM serine/threonine kinase (ATM)-dependent DNA damage response in host cells that suppresses viral replication. Viruses evolved different strategies to counteract this antiviral surveillance system.
Vanessa Collin, Élise Biquand, Vincent Tremblay, Élise G Lavoie, Andréanne Blondeau, Annie Gravel, Maxime Galloy, Anahita Lashgari, Julien Dessapt, Jacques Côté, Louis Flamand, Amélie Fradet-Turcotte   +11 more
doaj   +1 more source

Validation of the IFN-γ response to selected HHV-6B peptides.

, 2015
Peptide-expanded T cell cultures to each of the 14 peptides in Table 4 were generated for 3 donors, and tested for IFN-γ using ELISpot (SFU/106 cells). A.
Lawrence J. Stern (49046), Aniuska Becerra-Artiles (829447), Omar Dominguez-Amorocho (829448), J. Mauricio Calvo-Calle (80390)   +3 more
core   +1 more source

Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape

Viruses
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and is associated with pleiotropic manifestations in this setting,
Eleftheria Kampouri, Guy Handley, Joshua A. Hill   +2 more
doaj   +1 more source

Expression of MHC class I molecule in HHV‐6B‐infected cells [PDF]

Microbiology and Immunology, 2014
Megumi, Ota, Satoshi, Serada, Tetsuji, Naka, Yasuko, Mori   +3 more
openaire   +2 more sources

Differences i tropism and viral assembly pathways of human herpesvirus 6A and 6B (HHV-6A and 6B) and association of host cell proteins in HHV-6A virions

, 2007
Human herpesvirus 6A and 6B (HHV-6A and 6B) are considered to be T-lymphotropic viruses. The overall nucleotide sequence identity between the two variants is 90% and each differs by only nine variant-specific open reading frames. HHV-6A and 6B have often
Jenny Ahlqvist (19490293)
core  

Susceptibility of the adult T cell leukemia (ATL) cell lines to HHV-6B [PDF]

Leukemia, 1998
C F, Zhou, K, Abe, P, Wang, K, Yamamoto
openaire   +2 more sources